TG and neoplasm: In these cases, the TAA-AAbs may not only indicate that the results of a tumor marker’s measurements may not be reliable but also provide additional diagnostic information, such as in DTC patients with rising anti-thyroglobulin antibodies (TG-AAbs) (see Section 4.2).